List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1391 studies with search of: Open Studies | "Lymphatic Diseases"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Tumor Registry of Lymphatic Neoplasia
Condition: Malignant Lymphatic Diseases
Intervention:
2 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder;   Canale-Smith Syndrome
Intervention:
3 Recruiting Rapid on-Site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
Conditions: Lung Cancer;   Sarcoidosis;   Tuberculosis
Interventions: Procedure: Rapid on-site cytopathologic evaluation (ROSE);   Procedure: TBNA
4 Recruiting Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.
Condition: Hodgkin Lymphoma
Intervention: Drug: Everolimus (RAD001)
5 Recruiting Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling
Condition: Lymphadenopathy
Intervention: Procedure: Lymph Node Needle Tissue Collections
6 Recruiting Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
Conditions: Bone Marrow Transplantation;   Hematopoietic Stem Cell Transplantation;   Leukemia;   Acute Leukemia;   Acute Lymphocytic Leukemia;   Quality of Life;   Psychological Distress;   Multiple Myeloma
Interventions: Behavioral: Writing A (Experimental informative writing);   Behavioral: Writing B (Experimental noninformative writing);   Behavioral: Writing C (Control informative writing);   Behavioral: Writing D (Control noninformative writing)
7 Recruiting Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders;   Lymphoma
Intervention:
8 Recruiting Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
Conditions: Peripheral T Cell Lymphoma, Unspecified;   Angioimmunoblastic Lymphadenopathy;   AIL Type Lymphoma;   Anaplastic Large Cell Lymphoma, ALK Negative;   Extranodal NK/T-Cell Lymphoma
Interventions: Biological: alemtuzumab;   Drug: chemotherapy
9 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
10 Recruiting A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)
Conditions: Isolated Mediastinal Lymphadenopathy;   Sarcoidosis;   Tuberculosis;   Lung Cancer;   Lymphoma
Intervention: Procedure: EBUS
11 Recruiting Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: ALPS;   Hypersplenism;   Lymphadenopathy
Interventions: Drug: Valproic Acid;   Procedure: CT Scan;   Procedure: Blood Sample
12 Recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
13 Recruiting Therapy for Pediatric Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Intervention: Drug: 12 Week Stanford V Chemotherapy
14 Recruiting Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Conditions: Breast Cancer;   Lymphedema
Intervention: Device: Flexitouch
15 Recruiting Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Radiation: yttrium Y 90 ibritumomab tiuxetan
16 Recruiting Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Conditions: Tuberous Sclerosis;   Subependymal Giant Cell Astrocytoma
Interventions: Drug: Everolimus (RAD001);   Other: Placebo
17 Recruiting Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Conditions: Non-Hodgkins Lymphoma;   Hodgkins Lymphoma;   Multiple Myeloma
Intervention: Drug: Oncaspar, Doxil, Decadron
18 Recruiting Proton Therapy for Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Radiation: Proton Therapy;   Radiation: Conventional AP/PA;   Radiation: IMRT
19 Recruiting Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
Conditions: Relapsed Acute Lymphoblastic Leukemia;   Allergy to PEG e.Coli Asparaginase;   Allergy to Native e.Coli Asparaginase
Interventions: Drug: Erwinase;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Triple Intrathecal Therapy
20 Recruiting Combined Haploidentical-Cord Blood Transplantation for Adults and Children
Conditions: Leukemia;   Myelodysplastic Syndrome;   Multiple Myeloma;   Lymphoma
Interventions: Drug: Fludarabine-Melphalan & Rabbit antithymocyte globulin;   Procedure: Stem Cell Transplant;   Procedure: Stem Cells Collections

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options